Key facts
- Aveta System’s last known valuation is $150.0M.
- It has raised $129.0M; the latest was Later Stage VC ($86.6M) in May 2024.
- Notable investors include Alumni Ventures, Deerfield Management, ShangBay Capital, Monroe Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Aveta System
- ·The full record, as it builds
Funding rounds
No funding rounds for Aveta System are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aveta System
Developer of an integrated hysteroscopy device designed for intrauterine tissue removal procedures. The company's system combines fluid management, high-definition imaging, and single-use resecting devices, offering precise pressure control, electronic image stabilization, and physician-controlled functionality, enabling healthcare professionals to perform efficient hysteroscopy, reduce procedure costs, and enhance patient outcomes.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2016
- Employees
- 110
- Website
- avetasystem.com/
- Ownership
- Privately Held (backing)
Aveta System doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aveta System shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aveta System in its N-PORT filings yet. We sweep new filings monthly.